5
report
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical i
nnovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.
+ Read More
report
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development
New blood-based technologies, known as multi-cancer early detection (MCED) tests, are entering 
;the market and can identify multiple cancers early and simultaneously.
+ Read More
article
FasterCures Statement of Support for 21st Century Cures 2.0 Legislation
FasterCures, a center of the Milken Institute, has long supported policies that accelerate new, cutt
ing-edge biomedical innovations to patients.
+ Read More
article
Statement at Multi-Stakeholder meeting in support of the UN High-Level Meeting on Pandemic Prevention, Preparedness and Response
FasterCures would like to express our strong support for current initiatives to advance pandemic pre
vention, preparedness, and response. We appreciate the opportunity to provide our perspective in these critical discussions.
+ Read More
article
Request for Information: Advancing Clinical and Translational Science through Accelerating the Decentralization of Clinical Trials, NIH RFI Notice Number NOT-TR-23-006
Submitted electronically
Joni Rutter, Ph.D.
National Center for Advancing Translational Sciences
Na
tional Institutes of Health
6701 Democracy Blvd
Bethesda, MD 20892-4874
Dear Director Rutter,
+ Read More